Evidence generation throughout paediatric medicines life cycle: findings from collaborative work between European Medicines Agency (EMA) and EUnetHTA on use of extrapolation

Documenti analoghi

• Current Use of Physiologically Based Pharmacokinetic modeling in New Medicinal Product Approvals at EMA
  di: Polly Paul, et al.
  Pubblicazione: (2025)
• Reply to: “Current Use of PBPK Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus Nephritis”
  di: Polly Paul, et al.
  Pubblicazione: (2025)
• Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations
  di: Jorge Madrid Paredes, et al.
  Pubblicazione: (2024)
• The Eu-Angola Fisheries Agreement and Fisheries in Angola
  di: Lankester, K.
  Pubblicazione: ()
• Reemergencia de enfermedades prevenibles por vacunas: el caso del sarampión en las Américas
  di: Andres Benchetrit
  Pubblicazione: (2019)